Pro-Pharmaceuticals, Inc. (AMEX: PRW)

Pro-Pharmaceuticals, Inc. (AMEX: PRW), a development-stage company, is focused on the discovery, development, and commercialization of first-in-class, targeted therapeutic compounds designed to treat cancer, liver, microbial and inflammatory diseases. The company’s current focus is on developing a new generation of anti-cancer treatments by utilizing carbohydrate polymers to improve survival rates and improve the quality of life for cancer patients. For further information, visit the Company’s web site at www.pro-pharmaceuticals.com.